Vollmer, B. L., Nair, K. V., Sillau, S., Corboy, J. R., Vollmer, T., & Alvarez, E. (2018). Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol.
Chicago-стиль цитированияVollmer, Brandi L., Kavita V. Nair, Stefan Sillau, John R. Corboy, Timothy Vollmer, and Enrique Alvarez. "Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2018.
MLA-цитированиеVollmer, Brandi L., et al. "Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.